The mechanism of degeeeration of striatal neuronal subtypes in Huntington disease

Annals of Neurosciences

Volumn 21, Issue 3, 2014, Pages 112-114

  Rikani, Azadeh A ^a,b   Choudhry, Zia ^a,b,c   Choudhry, Adnan M ^c   Rizvi, Nasir ^d   Ikram, Huma ^e   Mobassarah, Nusrat J ^f   Tulli, Sagun ^g  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Division of Research and Medical Education International Maternal and Child Health Foundation   (Canada)

^d UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^e UNIVERSITY OF KARACHI   (Pakistan)

^f KYOTO UNIVERSITY   (Japan)

^g Center for Advanced Brain and Spine Surgery   (United States)

Author keywords

Huntington's disease; MSN; NMDA

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; NERVE GROWTH FACTOR; NEUROTROPHIC FACTOR;

BRAIN NERVE CELL; CORPUS STRIATUM; EXCITOTOXICITY; GENE EXPRESSION REGULATION; HISTOLOGY; HUNTINGTON CHOREA; INTERNEURON; MEDIUM SPINY NEURON; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROPROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 84907325125     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.210308     Document Type: Review

References (12)

1. Cicchettia F, Saportac S, Hausere RA, et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc. of Natl. Acad. Sci USA. 2009; 106: 12483-12488.
2. Precious Sophie V, Rosser Anne E. Producing striatal phenotypes for transplantation in Huntington's disease. Experimental Biology and Medicine. 2012; 237: 343-351.
3. Cicchetti F., Soulet D, Freeman TB. Neuronal degeneration in striatal transplants and Hundtington's disease: potential mechanisms and clinical implications. Brain, 2011; 134: 641-652.
4. Ina H, YiMei Y, Jeffrey H K, et al. Differential vulnerability of specific cell populations in HD and its relationship to morphological and biochemical characteristics. J Neurochem. 2010; 113(5): 1073-1091.
5. Coyle JT, Schwarcz R. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea. Nature, 1976; 263: 244-246.
6. Cicchetti F, Saporta S, Hauser RA, et al. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration. Proc Natl Acad Sci USA, 2009; 106: 12483-12488.
7. Funk CB, Prasad AN, Frosk P, et al. Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 2005; 128: 711-722.
8. Flott-Rahmel B, Falter C, Schluff P, et al. Nerve cell lesions caused by 3-hydroxyglutaric acid: a possible mechanism for neurodegeneration in glutaric acidaemia I. J Inherit Metab Dis. 1997; 20: 387-390.
9. Liu F, Patterson TA, Sadovova N, et al. Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. Toxicol. Sci. 2013; 131: 548-557.
10. Perez N, Alberch J, Neveu I, et al. Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4/5 differentially regulate the phenotype andprevent degenerative change in striatal projection neurons after excitotoxicity in vivo. Neuroscience. 1999; 91: 1257-1264.
11. Perez N, Arenas E, Marco S, et al. Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo. Eur. J. Neuroscience. 1999; 11: 241-249.
12. Josep MC, Sonia M, Nuria C, et al. Differential Regulation of The expression of Nerve Growth Factor, Brain-Derived Neurotrophic Factor, and Neurotrophic-3 after Excitotoxicity in a Rat Model of Huntington's Disease. Neurobiology of Disease. 1998; 5: 357-364.